Leucoencéphalopathie multifocale progressive chez une patiente immunocompétente

Pratique Neurologique - FMC - Tập 5 - Trang 209-213 - 2014
J. Boucher1,2, C. Tard1,2, L. Defebvre1,2
1Université Lille-Nord-de-France, université Droit et Santé, 42, rue Paul-Duez, 59000 Lille, France
2Service de neurologie et pathologie du mouvement, hôpital Roger-Salengro, 2, avenue Oscar-Lambret, 59037 Lille cedex, France

Tài liệu tham khảo

Eng, 2006, Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population, Neurology, 67, 884, 10.1212/01.wnl.0000233918.21986.9c Berger, 2013, PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section, Neurology, 80, 1430, 10.1212/WNL.0b013e31828c2fa1 Cinque, 2003, The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology, J Neurovirol, 9, 88, 10.1080/13550280390195298 Tan, 2010, Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis, Lancet Neurol, 9, 425, 10.1016/S1474-4422(10)70040-5 Richardson-Burns, 2002, Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS, Arch Neurol, 59, 1930, 10.1001/archneur.59.12.1930 Perez-Liz, 2008, Detection of JC virus DNA fragments but not proteins in normal brain tissue, Ann Neurol, 64, 379, 10.1002/ana.21443 Gheuens, 2010, Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression, J Neurol Neurosurg Psychiatry, 81, 247, 10.1136/jnnp.2009.187666 Khatri, 2009, Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function, Neurology, 72, 402, 10.1212/01.wnl.0000341766.59028.9d Aure, 2005, Dramatic improvement in non-aids related progressive multifocal leucoencephalopathy, J. Neurol Neurosurg Psychiatry, 76, 1305, 10.1136/jnnp.2004.061408 Cettomai, 2009, Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy, Arch Neurol, 66, 255, 10.1001/archneurol.2008.557 Clifford, 2013, A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes, J Neurovirol, 19, 351, 10.1007/s13365-013-0173-y Casado, 2014, Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era, Eur J Clin Microbiol Infect Dis, 33, 179, 10.1007/s10096-013-1941-6 Delbue, 2009, JC virus VP1 loop-specific polymorphisms are associated with favorable prognosis for progressive multifocal leukoencephalopathy, J Neurovirol, 15, 51, 10.1080/13550280802425467